Akèy › Kansè pénis
Etid klinik pou Kansè pénis ap rekrite nan Etazini
7 etid pou Kansè pénis ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT04923178Integrated Cancer Repository for Cancer Research
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT05686226E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT05639972Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 ak plis · Gason · Mizajou Jun 8, 2026 · NCT06104618Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Dec 4, 2025 · NCT05526989Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.